B cell–activating factor modulates the factor VIII immune response in hemophilia A-Reference-Cited by-同舟云学术

B cell–activating factor modulates the factor VIII immune response in hemophilia A

Published:2021-04-15 Issue:8 Volume:131 Page:
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Doshi Bhavya S.^ORCID,Rana Jyoti,Castaman Giancarlo,Shaheen Mostafa A.,Kaczmarek Radoslaw^ORCID,Butterfield John S.S.,Meeks Shannon L.^ORCID,Leissinger Cindy,Biswas Moanaro^ORCID,Arruda Valder R.^ORCID

Funder

Bayer Hemophilia Awards Program

American Society of Hematology

Hemophilia of Georgia

National Heart, Lung, and Blood Institute

National Hemophilia Foundation

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/142906/files/pdf

Reference108 articles.

1. Immunogenicity of protein therapeutics: The key causes, consequences and challenges

2. Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males

3. Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

4. A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

5. Detection of factor VIII inhibitors with the partial thromboplastin time;Lossing;Blood,1977

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers Involved in the Pathogenesis of Hemophilic Arthropathy;International Journal of Molecular Sciences;2024-09-13

2. Anti-mCD20 in combination with α-mCXCL13 monoclonal antibody inhibits anti-FVIII antibody development in hemophilia A mice;International Immunopharmacology;2024-09

3. Binding Promiscuity of Therapeutic Factor VIII;Thrombosis and Haemostasis;2024-07-01

4. Abnormal frequency of the memory B cell subsets and plasmablasts in patients with congenital severe hemophilia A: correlation with “Inhibitor” formation;Blood Research;2024-04-16

5. B cell focused transient immune suppression protocol for efficient AAV readministration to the liver;Molecular Therapy - Methods & Clinical Development;2024-03